Superworth

Pro DEX EPS PDEX

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Sep 30, 2026
$3.63
Latest quarter, Q1 FY27
$0.92
−34% on a year earlier
Fiscal year 2026
$4.11
+52% on the year before

Pro DEX's earnings per share was $3.63 over the twelve months to Sep 30, 2026, up 8% on a year earlier.

In its latest quarter, Q1 FY27, it was $0.92, down 34% on the same quarter a year before.

Over the five fiscal years to FY2026 it grew 21% a year on average.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2026$4.11+52%
FY2025$2.70+335%
FY2024$0.62−68%
FY2023$1.95+61%
FY2022$1.21−23%
FY2021$1.57+5%
FY2020$1.50+55%
FY2019$0.97+155%
FY2018$0.38−70%
FY2017$1.25+525%
FY2016$0.20n/a
FY2015−$0.09n/a
FY2014−$0.15n/a
FY2013−$0.54n/a
FY2012−$0.27−134%

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q1 FY27$0.92−34%$3.63
Q4 FY26$0.85+136%$4.11
Q3 FY26$1.20+22%$3.62
Q2 FY26$0.66+8%$3.40
Q1 FY26$1.40+87%$3.35
Q4 FY25$0.36−22%$2.70
Q3 FY25$0.98+416%$2.80
Q2 FY25$0.61+336%$2.01
Q1 FY25$0.75n/a$1.54
Q4 FY24$0.46+10%$0.62
Q3 FY24$0.19−58%$0.58
Q2 FY24$0.14−81%$0.84

Against its peers

Companies in Medical - Instruments & Supplies nearest Pro DEX's size, closest first, today.

CompanyEPS, 12 monthsGrowth
PDEXPro DEX$3.63+8% a year
UTMDUtah Medical Products$3.28−12% a year
INFUInfuSystem$0.41+78% a year
EMBCEmbecta$1.47+3% a year
KEQUKewaunee Scientific$2.76−33% a year
TCMDTactile Systems Technology$1.08+74% a year
APTAlpha Pro Tech$0.41+24% a year
MOVMovado$1.80+137% a year
NEPHNephros$0.16+33% a year
IRMDIradimed$1.87+13% a year
IARTIntegra Lifesciences$0.17
Peer median$1.27

Where Pro DEX ranks

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Pro DEX

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.